ArticleWorld journal of microbiology & biotechnology2026
L-arginine functionalized NiFe₂O₄ nanoparticles: synthesis, characterization, antimicrobial activity, and biocompatibility evaluation in a zebrafish model.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NiFe₂O₄ nanoparticles and L-arginine–functionalized NiFe₂O₄ (NiFe₂O4–LA) were synthesized, characterized, and evaluated for antimicrobial performance and in vivo biocompatibility in a zebrafish embryo model. The XRD and HRTEM studies confirmed the formation of single-phase cubic spinel NiFe₂O₄ with average crystallite size ≈ 20–30 nm. Surface modification with LA preserved the spinel structure while reducing crystallinity and hydrodynamic size 128.7 nm. FTIR and XPS verified successful surface functionalization. UV vis measurements showed band-gap narrowing after La conjugation (Eg ≈ 3.23 → 3.15 eV). NiFe₂O₄–LA exhibited enhanced antimicrobial activity compared with bare NiFe₂O₄ against MRSA and C. albicans an effect attributed to enhanced surface interaction and ROS-mediated oxidative damage. The MIC values of C. albicans is found to 1200 µg/mL while in the case MRSA is about 900 µg/mL. The ROS assays with histidine modulation supported a role for redox activity in antimicrobial action. In vivo zebrafish embryo assays showed minimal developmental toxicity at tested exposures with better viability for the LA coated material.
Indexed as
Identifiers
41811582What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.